Cargando…

Long-term prognostic value of mitral regurgitation in acute coronary syndromes

OBJECTIVES: To determine the additional prognostic value of mitral regurgitation (MR) over B-type natriuretic peptide (BNP), left ventricular ejection fraction (LVEF) and clinical characteristics in patients with acute coronary syndromes (ACS). DESIGN: Long-term follow-up in a prospective ACS cohort...

Descripción completa

Detalles Bibliográficos
Autores principales:	Persson, Anita, Hartford, Marianne, Herlitz, Johan, Karlsson, Thomas, Omland, Torbjørn, Caidahl, Kenneth
Formato:	Texto
Lenguaje:	English
Publicado:	BMJ Group 2010
Materias:	Acute Coronary Syndromes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2976074/ https://www.ncbi.nlm.nih.gov/pubmed/20876739 http://dx.doi.org/10.1136/hrt.2010.203059

Ejemplares similares

The prognostic value of high sensitivity troponin T 7 weeks after an acute coronary syndrome
por: Ang, Donald S C, et al.
Publicado: (2012)

Troponins, Acute Coronary Syndrome and Renal Disease: From Acute Kidney Injury Through End-stage Kidney Disease
por: Banerjee, Debasish, et al.
Publicado: (2019)

Intravascular evaluation of coronary atherosclerotic lesions among Egyptian diabetic patients with acute coronary syndromes
por: Laimoud, Mohamed, et al.
Publicado: (2018)

Tissue characterization of non-culprit intermediate coronary lesions in non ST elevation acute coronary syndromes
por: Elghawaby, Helmy Hassan, et al.
Publicado: (2018)

Predictors of one-year mortality at hospital discharge after acute coronary syndromes: A new risk score from the EPICOR (long-tErm follow uP of antithrombotic management patterns In acute CORonary syndrome patients) study
por: Pocock, Stuart, et al.
Publicado: (2015)

Dyspnoea management in acute coronary syndrome patients treated with ticagrelor
por: Parodi, Guido, et al.
Publicado: (2015)

Patients with non-obstructive coronary artery disease admitted with acute myocardial infarction carry a better outcome compared to those with obstructive coronary artery disease
por: Abdelmonem, Yasser Yazied, et al.
Publicado: (2017)

Risk factors for acute coronary syndrome in patients below the age of 40 years
por: Mirza, Aram J., et al.
Publicado: (2018)

Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndrome
por: Mälarstig, A, et al.
Publicado: (2008)

Pre-hospital and hospital delay in patients with non-ST elevation acute coronary syndromes in tertiary care
por: Youssef, G.S., et al.
Publicado: (2017)

Ischemia modified albumin (IMA) in acute coronary syndrome (ACS) and left bundle branch block (LBBB). Does it make the difference?
por: Wahab, Mohamed Abdel Kader Abdel
Publicado: (2017)

Effect of chronic pretreatment with beta-blockers on no-reflow phenomenon in diabetic patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
por: Al-Jabari, Ali Mohammed Kareem, et al.
Publicado: (2017)

Type and timing of heralding in ST-elevation and non-ST-elevation myocardial infarction: an analysis of prospectively collected electronic healthcare records linked to the national registry of acute coronary syndromes
por: Herrett, Emily, et al.
Publicado: (2013)

Prevalence of lipid abnormalities and cholesterol target value attainment in Egyptian patients presenting with an acute coronary syndrome
por: Sobhy, Mohamed, et al.
Publicado: (2018)

Impact on mortality following first acute myocardial infarction of distance between home and hospital: cohort study
por: Wei, L, et al.
Publicado: (2008)

Early glycoprotein IIb–IIIa inhibitors in primary angioplasty (EGYPT) cooperation: an individual patient data meta-analysis
por: De Luca, G, et al.
Publicado: (2008)

Newly diagnosed glucose intolerance and prognosis after acute myocardial infarction: comparison of post-challenge versus fasting glucose concentrations
por: Tamita, Koichi, et al.
Publicado: (2012)

Cardiovascular effects of tumour necrosis factor α antagonism in patients with acute myocardial infarction: a first in human study
por: Padfield, Gareth J, et al.
Publicado: (2013)

Strategic target temperature management in myocardial infarction—a feasibility trial
por: Testori, Christoph, et al.
Publicado: (2013)

Transradial artery approach in STEMI patients reperfused early and late by either primary PCI or pharmaco-invasive approach()()
por: Sultan, El-Zahraa M., et al.
Publicado: (2018)

Novel Aspects of Classification, Prognosis and Therapy in Takotsubo Syndrome
por: Di Filippo, Chiara, et al.
Publicado: (2019)

Prognostic value of circulating chromogranin A levels in acute coronary syndromes
por: Jansson, Anna M., et al.
Publicado: (2009)

Clinical role of serum Copeptin in acute coronary syndrome
por: Abd El Baky Mahmoud, Manal, et al.
Publicado: (2018)

The Caprini Risk Score for Early Prediction of Mortality in Patients With Acute Coronary Syndrome
por: Li, Wentao, et al.
Publicado: (2023)

Incidence and predictors of bleeding among Egyptian patients presenting with acute coronary syndrome: Using CRUSADE risk score
por: Morttada, Ayman, et al.
Publicado: (2018)

Right ventricular function in patients presenting with non-ST-segment elevation myocardial infarction undergoing an invasive approach
por: Elserafy, Ahmed Shawky, et al.
Publicado: (2018)

Death anxiety in patients with myocardial infarction or cancer
por: Şahan, Ebru, et al.
Publicado: (2018)

LB-3 | Sex Differences in Clinical Characteristics, Management Strategies and Outcomes of STEMI Patients with COVID-19
por: Quesada, Odayme, et al.
Publicado: (2022)

Sex Differences in Patient-Reported Outcomes in the Immediate Recovery Period After Resuscitation: Findings From the Cross-sectional DenHeart Survey
por: Wagner, Mette Kirstine, et al.
Publicado: (2023)

Adjunctive Techniques for Repair of Ischaemic Mitral Regurgitation
por: Johannesen, Sigrid L, et al.
Publicado: (2021)

Early intravenous beta-blockers in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A patient-pooled meta-analysis of randomized clinical trials
por: Hoedemaker, Niels PG, et al.
Publicado: (2019)

Prognostic Biomarkers in Acute Coronary Syndromes: Risk Stratification Beyond Cardiac Troponins
por: Eggers, K. M., et al.
Publicado: (2017)

Multiple percutaneous coronary interventions worsen outcomes for subsequent surgical correction of chronic ischemic mitral regurgitation
por: Kainuma, Satoshi, et al.
Publicado: (2021)

LB-11 | Core-Laboratory Angiographic Characteristics and Mortality of Patients With STEMI and COVID-19: Insights from the NACMI Registry
por: Dehghani, Payam, et al.
Publicado: (2023)

Prognostic value of circulating chromogranin A levels in acute coronary syndrome: reply
por: Røsjø, Helge, et al.
Publicado: (2010)

Outcomes of ischaemic mitral regurgitation in anterior versus inferior ST elevation myocardial infarction
por: Mentias, Amgad, et al.
Publicado: (2016)

Invasive Therapies for Acute Coronary Syndromes in the COVID-19 Era
por: Borgaonkar, Sanket, et al.
Publicado: (2021)

Management of Multivessel Coronary Disease in ST-segment Elevation Myocardial Infarction
por: Banning, Amerjeet S., et al.
Publicado: (2015)

Prognostic Value of Myocardial Blush Grade in ST-elevation MI: A Systematic Review and Meta-analysis
por: Vera Cruz, Patrick, et al.
Publicado: (2022)

Thrombolytic Therapy for ST-Elevation Myocardial Infarction Presenting to non-Percutaneous Coronary Intervention Centers During the COVID-19 Crisis
por: Walters, Daniel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v8v2gd5bfg53pm3cumdm9l8nsd